Insider Trading & Ownership - Santos David A

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Santos David A
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-02-02
Sale
2024-02-06
8:18 pm
RIGEL PHARMACEUTICALS INCRIGLSantos David A
EVP, Chief Commercial Officer
14,519$1.1361$16,496349,093
(Direct)
View
2023-02-02
Sale
2023-02-06
5:41 pm
RIGEL PHARMACEUTICALS INCRIGLSantos David A
EVP, Chief Commercial Officer
5,388$1.6602$8,945144,612
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-11-25
Option Award
2024-11-26
8:01 pm
N/A
2033-01-26
RIGEL PHARMACEUTICALS INCRIGLSantos David A
EVP, Chief Commercial Officer
8,000$08,000
(Direct)
View
2024-02-28
Option Award
2024-03-01
7:15 pm
N/A
2033-01-26
RIGEL PHARMACEUTICALS INCRIGLSantos David A
EVP, Chief Commercial Officer
158,500$0158,500
(Direct)
View
2024-01-23
Option Award
2024-01-25
9:17 pm
N/A
2034-01-23
RIGEL PHARMACEUTICALS INCRIGLSantos David A
EVP, Chief Commercial Officer
366,000$0520,612
(Direct)
View
2023-01-26
Option Award
2023-01-30
9:45 pm
N/A
2032-01-24
RIGEL PHARMACEUTICALS INCRIGLSantos David A
EVP, Chief Commercial Officer
290,000$0410,000
(Direct)
View
2022-12-28
Option Award
2022-12-30
4:30 pm
N/A
2032-01-24
RIGEL PHARMACEUTICALS INCRIGLSantos David A
EVP, Chief Commercial Officer
50,000$050,000
(Direct)
View
2022-01-24
Option Award
2022-01-26
8:45 pm
N/A
2032-01-24
RIGEL PHARMACEUTICALS INCRIGLSantos David A
EVP, Chief Commercial Officer
150,000$0160,000
(Direct)
View
2021-01-27
Option Award
2021-01-29
7:08 pm
N/A
2031-01-27
RIGEL PHARMACEUTICALS INCRIGLSantos David A
EVP, Chief Commercial Officer
137,500$0137,500
(Direct)
View
2020-08-19
Option Award
2020-08-20
7:19 pm
N/A
2030-08-19
RIGEL PHARMACEUTICALS INCRIGLSantos David A
EVP, Chief Commercial Officer
250,000$0250,000
(Direct)
View